ANSM unveils temporary scientific committee on «implementation of medical cannabis trials in France».»
After ANSM's Temporary Specialized Scientific Committee (CSST) which validated the need to implement the Temporary Scientific Committee (CST) for the «implementation of medical cannabis trials in France».
Lasting 6 months, the CST will study the conditions for experimenting with therapeutic cannabis in France. Like we unveiled it 15 days ago, At least 3 topics will be on the agenda: product specifications, patient registers and training resources for healthcare staff.
According to the decision of ANSM, the STC will be composed of :
- Nicolas AUTHIER as Chairman of the CST. He already chaired the previous CSST on medical cannabis.
- Philippe ANDRIEUX, of the Principes Actifs association
- Nadine ATTAL, neurologist by training, pain specialist
- Lucas BEURTON-COURAUD, general practitioner in Finistère, France
- Pierre CHAMPY, Professor of Pharmacognosy
- Laure COPEL, oncologist and head of the Palliative Care Unit at the Diaconesses Croix Saint-Simon Hospital Group
- Patrick DAIME, general practitioner and representative of the Conseil National de l'Ordre des Médecins (Cnom)
- Carole DE MULATIER, Project Manager, Union pour la lutte contre la sclérose en plaques (UNISEP)
- Vera DINKELACKER, neurologist
- Samira DJEZZAR, hospital doctor and member of addictovigilance IDF
- Antoine DUPUIS, Professor of Pharmacy
- Yannick FRELAT, member of Epilepsie France
- Marie-Madeleine GILANTON, spokesperson for the 'Espoir (Im)patient' association, President of APAISER (Association Pour Aider et Informer les Syringoméliques Européens Réunis) and member of the Alliance Maladies Rares.
- René MAAREK, pharmacist, member of the Union des syndicats de pharmaciens d'officine (Upso)
- Alexandre MACIUK, Doctor of Pharmacy and Senior Lecturer
- Bertrand RAMBAUD, President, UFCM-I Care
- Catherine SEBIRE, Director, Association francophone pour vaincre les douleurs (AFVD)
- Melissa YELEHE, Doctor of Pharmacy at Nancy University Hospital
The schedule for CST meetings has not yet been announced.
-
Cannabis in Africa2 weeks ago
Nigeria moves a step closer to legalizing medical cannabis
-
Cannabis in France2 weeks ago
Le Champ d’en Face aims to bring hemp back into the public discourse
-
Cannabis in France2 weeks ago
French CBD industry to challenge CBD product control plan in court
-
Business6 days ago
Europe authorizes the first cannabis-derived medicine for the treatment of chronic pain
-
Cannabis in the Caribbean2 weeks ago
Antigua and Barbuda: When Cannabis Becomes a Cultural Destination and a Tool for Sovereignty
-
Cannabinoids2 weeks ago
Japan bans CBN
-
Business2 weeks ago
Germany imported over 50 tonnes of medical cannabis in the first quarter of 2026
-
Cannabis in the U.S.2 weeks ago
Trump's reclassification of cannabis is being challenged in court


pilila
October 16, 2019 at 19 h 36 min
So let them experiment! What the hell! Mix twice rather than once! They don't have to rely on the thousands of favorable scientific studies, specifying doses and desirable distribution methods, which have been available for at least ten years on the Internet and in specialized scientific journals.
In any case, as we all know, France is a country of extraterrestrials who don't react at all like the Americans, Australians, Israelis and so on.
We need home-grown protocols!
We're not like everyone else all the same, just a little more stupid!!!!